Trial Outcomes & Findings for Calcium Absorption in Patients With Rothmund-Thomson Syndrome (NCT NCT01304407)
NCT ID: NCT01304407
Last Updated: 2020-07-23
Results Overview
Individuals had low areal bone mineral density (aBMD) assessed by DXA using a Hologic Delphi-A instrument (Bedford, MA) at the Body Composition Laboratory of the Children's Nutrition Research Center, Houston, TX. Scans were performed of the whole body, lumbar spine, and proximal femur. Bone mineral content (BMC), bone area, and BMD were measured using Hologic Discovery V12.1 analysis software. For adult subjects, BMD Z-scores of the whole body, lumbar spine, left total hip, and left femoral neck were calculated using the Hologic Reference Database. Validated age- and sex-matched control data from the pediatric population generated by the Body Composition Laboratory of the Children's Nutrition Research Center, Houston, TX were used to calculate the Z-scores for pediatric subjects as previously published.
COMPLETED
NA
29 participants
8 days
2020-07-23
Participant Flow
The isotope tracer is used as a method to evaluate calcium absorption.
Participant milestones
| Measure |
RTS Patients
Rothmond-Thompson patients receiving 5 mg 42Ca, 46Ca stable isotopes to evaluate bone calcium deposition
|
|---|---|
|
Overall Study
STARTED
|
29
|
|
Overall Study
COMPLETED
|
29
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Calcium Absorption in Patients With Rothmund-Thomson Syndrome
Baseline characteristics by cohort
| Measure |
RTS Patients
n=29 Participants
Rothmond-Thompson patients receiving 5 mg 42Ca, 46Ca stable isotopes to evaluate bone calcium deposition
|
|---|---|
|
Age, Categorical
<=18 years
|
20 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
9 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
5 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
16 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
13 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
29 count of participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 8 daysPopulation: Areal bone mineral density (aBMD) z-scores of 13 pediatric patients, 9 adult patients. 7 of the patients did not have successful bone density scans to be included in the analysis.
Individuals had low areal bone mineral density (aBMD) assessed by DXA using a Hologic Delphi-A instrument (Bedford, MA) at the Body Composition Laboratory of the Children's Nutrition Research Center, Houston, TX. Scans were performed of the whole body, lumbar spine, and proximal femur. Bone mineral content (BMC), bone area, and BMD were measured using Hologic Discovery V12.1 analysis software. For adult subjects, BMD Z-scores of the whole body, lumbar spine, left total hip, and left femoral neck were calculated using the Hologic Reference Database. Validated age- and sex-matched control data from the pediatric population generated by the Body Composition Laboratory of the Children's Nutrition Research Center, Houston, TX were used to calculate the Z-scores for pediatric subjects as previously published.
Outcome measures
| Measure |
RTS Patients
n=22 Participants
Rothmond-Thompson patients receiving 5 mg 42Ca, 46Ca stable isotopes to evaluate bone calcium deposition
|
|---|---|
|
Bone Density (Low Areal Bone Mineral Density (aBMD))
13 pediatric patients, whole body aBMD
|
-1.3 z-score
Interval -1.6 to -0.4
|
|
Bone Density (Low Areal Bone Mineral Density (aBMD))
9 adult patients, whole body aBMD
|
-0.9 z-score
Interval -1.2 to 0.94
|
|
Bone Density (Low Areal Bone Mineral Density (aBMD))
13 pediatric patients, lumbar spine aBMD
|
-2.4 z-score
Interval -2.9 to -1.7
|
|
Bone Density (Low Areal Bone Mineral Density (aBMD))
9 adult patients, lumbar spine aBMD
|
-1.2 z-score
Interval -1.8 to 0.1
|
|
Bone Density (Low Areal Bone Mineral Density (aBMD))
13 pediatric patients, femoral neck aBMD
|
-2.4 z-score
Interval -3.3 to -1.1
|
|
Bone Density (Low Areal Bone Mineral Density (aBMD))
9 adult patients, femoral neck aBMD
|
-0.8 z-score
Interval -1.5 to 0.3
|
|
Bone Density (Low Areal Bone Mineral Density (aBMD))
13 pediatric patients, total hip aBMD
|
-1.5 z-score
Interval -2.4 to -0.2
|
|
Bone Density (Low Areal Bone Mineral Density (aBMD))
9 adult patients, total hip aBMD
|
-0.7 z-score
Interval -1.5 to 0.1
|
Adverse Events
RTS Patients
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place